4//SEC Filing
Hopman Mark 4
Accession 0001415889-25-015670
CIK 0001674632other
Filed
Jun 3, 8:00 PM ET
Accepted
Jun 4, 7:30 PM ET
Size
9.0 KB
Accession
0001415889-25-015670
Insider Transaction Report
Form 4
Hopman Mark
Chief Commercial Officer
Transactions
- Sale
Common Stock
2025-06-02$18.15/sh−551$10,000→ 34,211 total - Sale
Common Stock
2025-06-02$17.03/sh−238$4,053→ 34,762 total - Sale
Common Stock
2025-06-02$18.69/sh−79$1,477→ 34,132 total
Footnotes (4)
- [F1]The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units.
- [F2]The weighted average sale price for the transaction reported was $17.028 and the range of prices were between $16.62 and $17.56. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- [F3]The weighted average sale price for the transaction reported was $18.1489 and the range of prices were between $17.62 and $18.60. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- [F4]The weighted average sale price for the transaction reported was $18.691 and the range of prices were between $18.69 and $18.73. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
Documents
Issuer
Beta Bionics, Inc.
CIK 0001674632
Entity typeother
Related Parties
1- filerCIK 0002048497
Filing Metadata
- Form type
- 4
- Filed
- Jun 3, 8:00 PM ET
- Accepted
- Jun 4, 7:30 PM ET
- Size
- 9.0 KB